Skip to main content

NeuroTX

Category: AI in Healthcare

A medical deep-tech startup developing AI-powered non-invasive neurostimulation (electroceuticals) and digital therapeutics to treat sleep disorders and cognitive decline. NeuroTX was founded in 2015. The company is led by Dong-Joo Kim. Based in Seoul, South Korea. Team size: 10-20. Total funding raised: $1.0M+. Latest round: Series A (Imminent/Closing as of Jan 2025). Key investors include Kakao Ventures, TIPS (South Korean Government).

Founded
2015
Headquarters
Seoul, South Korea
Team size
10-20
Total funding
$1.0M+

Value proposition

Offers drug-free, non-invasive neurological stabilization and cognitive enhancement through AI-driven stimulation that synchronizes with the user's real-time brain activity.

Products and solutions

Willsleep (윌슬립): A compact, neck-adhered non-invasive Vagus Nerve Stimulation (nVNS) device for improving sleep quality and reducing stress., Willcog (윌코그): A digital therapeutic platform focused on cognitive enhancement and dementia prevention through sleep-synchronized stimulation., WillEP: A broader AI-powered electroceutical platform for personalized mental health management.

Unique value

Utilizes a closed-loop system that delivers phase-locked stimulation (electrical or auditory) precisely synchronized with the user's slow-wave sleep oscillations to maximize therapeutic efficacy.

Target customer

Individuals suffering from insomnia, anxiety, and depression; elderly patients with Mild Cognitive Impairment (MCI); healthcare providers specializing in neurology.

Industries served

Digital Therapeutics (DTx), Electroceuticals, Sleep Technology, Healthcare AI, Medical Devices

Technology advantage

Combines medical-grade bio-signal analysis with a consumer-friendly wearable form factor; clinical trials showed an 82% improvement in sleep quality (PSQI) and an 80% reduction in insomnia symptoms (ISI).

How they differentiate

NeuroTX utilizes a proprietary closed-loop system that delivers personalized, non-invasive transcutaneous vagus nerve stimulation (nVNS) precisely synchronized with the user's real-time bio-signals (EEG/Slow-wave oscillations) to maximize slow-wave sleep efficacy.

Main competitors

Pulsetto, Nurosym (Parasym), Amolux (Amolife), electroCore (gammaCore)

Key partnerships

University of Cambridge (Research collaboration), Seoul National University Hospital (Clinical trials), Korea University BrainLab (Foundational technology and R&D), Kakao Ventures (Early-stage investment), South Korean Government (TIPS program selection)

Notable customers

Seoul National University Hospital (Clinical Partner), Korea University Anam Hospital, University of Cambridge (Research Partner)

Major milestones

Rebranded from AutoTX to NeuroTX to focus on global mental health markets, Selected for the South Korean government's TIPS (Tech Incubator Program for Startup), Named a CES 2025/2026 Innovation Award Honoree for its flagship 'Willsleep' device, Established strategic R&D partnership with the University of Cambridge

Growth metrics

Clinical trials demonstrated an 82% improvement in sleep quality (PSQI) and an 80% reduction in insomnia severity (ISI).

Market positioning

Medical deep-tech bridging consumer wellness wearables and clinical-grade digital therapeutics (DTx).

Geographic focus

South Korea, North America (USA), and Europe (UK/University of Cambridge collaboration).

Patents and IP

Holds multiple intellectual property rights related to transcutaneous vagus nerve stimulation (nVNS) hardware, adhesive electrode designs, and proprietary AI algorithms for real-time EEG signal processing and adaptive stimulation.

About Dong-Joo Kim

Professor at Korea University's Department of Brain and Cognitive Engineering and Lead Researcher at the Korea University BrainLab. He is a prominent expert in brain-computer interfaces (BCI) and neuroscience, with over 20 years of research experience spanning South Korea and international collaborations. He founded NeuroTX (formerly AutoTX) to translate advanced brain signal analysis into commercial medical and wellness solutions.

Official website: